JFGIW
NRXPW

Johnson Financial Group Inc (Wisconsin)’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-315
Closed -$15 – 946
2024
Q3 		$15 Buy
+315
New +$23 ﹤0.01% 911

Other funds holding NRXPW

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s NRXPW Position: Q4 2024 in Review

Johnson Financial Group Inc (Wisconsin) sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2024, closing a stake of 315 shares — an estimated $15 sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in NRXPW in Q3 2024 and held it in 1 quarter. The position peaked at $15 in Q3 2024. 5 funds tracked by Wall St. Rank hold NRXPW as of Q4 2024.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2024 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 315 NRX Pharmaceuticals Warrant shares in Q4 2024, an estimated $15.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in NRX Pharmaceuticals Warrant in Q3 2024 and held it in 1 quarter.
  • Johnson Financial Group Inc (Wisconsin)'s NRX Pharmaceuticals Warrant position peaked at $15 in Q3 2024.
  • 5 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2024.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q4 2024, filed 14 Feb 2025.